EUVIMEDEUVIMED entdecken
Crossref

The consequences of manipulating relaxin family peptide receptor 1 (RXFP1) level in ovarian cancer cells

Kamila Domińska, Kinga Anna Urbanek, Karolina Kowalska, Dominika Ewa Habrowska-Górczyńska, Marta Justyna Kozieł, Tomasz Ochędalski, Agnieszka Wanda Piastowska-Ciesielska

Reproductive Biology · 2024-06 · 24 (2) · 100864

DOI: 10.1016/j.repbio.2024.100864 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Reproductive Biology, 2024-06. Verfasst von Kamila Domińska und 6 weiteren Autor:innen. Beteiligte Einrichtung: Medical University of Lodz, Department of Comparative Endocrinology, Zeligowskiego 7/9, 90-752 Lodz, Poland. Electronic address: kamila.dominska@umed…. Hauptthemen laut MEDLINE: Receptors, G-Protein-Coupled, Ovarian Neoplasms, Cell Proliferation. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 35 Literaturangaben. Gefördert von: Medical University of Lodz, Narodowym Centrum Nauki, National Science Centre Poland.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Deregulation of the relaxin family peptide system (RFPS) appears to increase the risk of range of cancers, including epithelial ovarian cancers (EOC). The present study examines the effect of relaxin family peptide receptor 1 (RXFP1) level on the biological properties of human epithelial ovarian adenocarcinoma cells (OVCAR4 and SKOV3). RXFP1 was downregulated (RXFP1↓) in the cells using the RXFP1 sgRNA CRISPR All-in-One Lentivirus set (pLenti-U6-sgRNA-SFFV-Cas9-2A-Puro), and upregulated (RXFP1↑) using the RXFP1 CRISPRa sgRNA Lentivector (pLenti-U6-sgRNA-PGK-Neo) kit, which activates the RXFP1 gene when paired with dCas9-SAM. The changes taking place during adhesion to extracellular matrix (ECM) proteins were assessed in multi-well plates coated with collagen, fibronectin, laminin and gelatin. Cellular viability was monitored based on mitochondrial metabolic activity (MTT Assay, Alamar Blue Assay) and adenosine triphosphate production (ATP Assay). The rate of cell proliferation was determined based on the percentage of Ki67 immunoreactive cells and the numbers of cells in particular cell-cycle phases. The mesenchymal-like (Boyden Chamber Assay) and amoeboid-like movements (Wound Healing Assay) of ovarian cancer cells were also analyzed after transfection. RXFP1 downregulation decreased the adhesion properties of ovarian cancer cells and increased the tendency for apoptosis under stressful conditions. In contrast, RXFP1 upregulation had pro-proliferative, pro-survival and promigratory effects. Our findings confirm that the relaxin-2/RXFP1 signaling pathway plays a role in the promotion of growth and progression of ovarian cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptors, G-Protein-CoupledOvarian NeoplasmsCell ProliferationHumansFemaleCell Line, TumorReceptors, PeptideCarcinoma, Ovarian EpithelialGene Expression Regulation, NeoplasticCell MovementRelaxinCell Adhesion

Stichwörter der Autor:innen

NF-kBOvarian cancerRXFP1Relaxin-2

Substanzen

Receptors, G-Protein-CoupledRXFP1 protein, humanReceptors, PeptideRelaxin

Autor:innen und Institutionen

  • Medical University of Lodz, Department of Comparative Endocrinology, Zeligowskiego 7/9, 90-752 Lodz, Poland. Electronic address: kamila.dominska@umed.lodz.pl.
  • Medical University of Lodz, Department of Cell Cultures and Genomic Analysis, Zeligowskiego 7/9, 90-752 Lodz, Poland.
  • Medical University of Lodz, Department of Comparative Endocrinology, Zeligowskiego 7/9, 90-752 Lodz, Poland.

Förderung

  • Medical University of Lodz
  • Narodowym Centrum Nauki
  • National Science Centre Poland

Zitieren

APA

Domińska, K., Urbanek, K. A., Kowalska, K., Habrowska-Górczyńska, D. E., Kozieł, M. J., Ochędalski, T., & Piastowska-Ciesielska, A. W. (2024). The consequences of manipulating relaxin family peptide receptor 1 (RXFP1) level in ovarian cancer cells. Reproductive Biology, 24(2), 100864. https://doi.org/10.1016/j.repbio.2024.100864

Vancouver

Domińska K, Urbanek KA, Kowalska K, Habrowska-Górczyńska DE, Kozieł MJ, Ochędalski T, et al. The consequences of manipulating relaxin family peptide receptor 1 (RXFP1) level in ovarian cancer cells. Reproductive Biology. 2024;24(2):100864. doi:10.1016/j.repbio.2024.100864

BibTeX
@article{Domiska2024,
  author = {Domińska, Kamila and Urbanek, Kinga Anna and Kowalska, Karolina and Habrowska-Górczyńska, Dominika Ewa and Kozieł, Marta Justyna and Ochędalski, Tomasz and Piastowska-Ciesielska, Agnieszka Wanda},
  title = {The consequences of manipulating relaxin family peptide receptor 1 (RXFP1) level in ovarian cancer cells},
  journal = {Reproductive Biology},
  year = {2024},
  volume = {24},
  number = {2},
  pages = {100864},
  doi = {10.1016/j.repbio.2024.100864}
}
Kostenlos starten →